ESR1 and breast carcinoma: This is the first report documenting a differential response to 1,25D3 in relation to cell proliferation, transactivation of vitamin D target gene, CYP24A1 and modulation of estrogen receptor signaling among the two VDR alleles in breast cancer cells.